New Strategies for Managing Single-Use Components

Publication
Article
BioPharm InternationalBioPharm International-06-15-2019
Volume 2019 eBook
Issue 2
Pages: 10–13

Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy, but must be applied correctly.

As single-use systems (SUS) have increasingly been implemented in GMP biopharmaceutical production, supply-chain assurance for SUS materials, components, and assemblies has become even more important. Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy. However, these tenets of supply-chain management are often misapplied and undervalued, leading to potential risk that can result in delays or even stoppages in critical drug production.

Read this article in BioPharm International's Single-Use Systems 2019 eBook.

Article Details

BioPharm International
eBook: Single-Use Systems 
Vol. 32
June 2019
Pages: 10–13

Citation

When referring to this article, please cite it as T. Korwan and J. Harp, " New Strategies for Managing Single-Use Components," BioPharm International Single-Use Systems eBook (June 2019).

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.